Development of Delivery System: design, documentation, IP (right to practice, Patents), equipment;
Drug Formulation Development: R&D, formulation, IP (right to practice, Patents), analytical and microbiological method developments, method validations, stability program;
Clinical Study Management: clinical batches, study design, study protocol, study monitoring;
Regulatory: pre-IND, IND, pre-NDA meeting data packages, eCTD NDA submission to achieve Market Approval;
Regulatory Affairs Consultants: Aside having knowledges of FDA regulatory/clinical requirements, we also have experiences with Health Canada, TGA, EU and MHRA requirements.
In addition, and most important, provide a pathway for “SPEED to Market” because of our cumulated experiences of over 60 years in this topical antimicrobial market.